Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/183759
Title: | Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients |
Author: | Gutiérrez, Ana Zapater, Pedro Ricart, Elena GonzálezVivó, María Gordillo, Jordi Olivares, David Vera, Isabel Mañosa, Míriam Gisbert, Javier P. Aguas, Mariam Sánchez Rodríguez, Eugenia Boscá Watts, Maia Laredo, Viviana Camps, Blau Marín Jiménez, Ignacio Zabana, Yamile Martín Arranz, María Dolores Muñoz, Roser Navarro, Mercè Sierra, Eva Madero, Lucía Vela, Milagros Pérez Calle, José Lázaro Sainz, Empar Calvet, Xavier Arias, Lara Morales, Victor Bermejo, Fernando Fernández Salazar, Luis Domselaar, Manuel van Castro, Luisa de Rodríguez, Cristina Muñoz Villafranca, Carmen Lorente, Rufo Rivero, Montserrat Iglesias, Eva Herreros, Belén Busquets, David Riera, Joan Martínez Montiel, María Pilar Roldón, Marta Roncero, Oscar Hinojosa, Esther Sierra, Mónica Barrio, Jesús Francisco, Ruth de Huguet, José Merino, Olga Carpio, Daniel Ginard, Daniel Muñoz, Fernando Piqueras, Marta Almela, Pedro Argüelles Arias, Federico Alcaín, Guillermo Bujanda, Luis Manceñido, Noemí Lucendo, Alfredo J. Varela, Pilar Rodríguez Lago, Iago Ramos, Laura Sempere, Laura Sesé, Eva Barreiro de Acosta, Manuel Domènech, Eugeni Francés, Rubén |
Keywords: | Malalties inflamatòries intestinals Fenotip Inflammatory bowel diseases Phenotype |
Issue Date: | 1-Feb-2022 |
Publisher: | Frontiers Media SA |
Abstract: | BackgroundPrevious studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused on the immigrant IBD population in Spain. MethodsProspective, observational, multicenter study comparing cohorts of IBD patients from ENEIDA-registry who were born outside Spain with a cohort of native patients. ResultsWe included 13,524 patients (1,864 immigrant and 11,660 native). The immigrants were younger (45 +/- 12 vs. 54 +/- 16 years, p < 0.001), had been diagnosed younger (31 +/- 12 vs. 36 +/- 15 years, p < 0.001), and had a shorter disease duration (14 +/- 7 vs. 18 +/- 8 years, p < 0.001) than native patients. Family history of IBD (9 vs. 14%, p < 0.001) and smoking (30 vs. 40%, p < 0.001) were more frequent among native patients. The most prevalent ethnic groups among immigrants were Caucasian (41.5%), followed by Latin American (30.8%), Arab (18.3%), and Asian (6.7%). Extraintestinal manifestations, mainly musculoskeletal affections, were more frequent in immigrants (19 vs. 11%, p < 0.001). Use of biologics, mainly anti-TNF, was greater in immigrants (36 vs. 29%, p < 0.001). The risk of having extraintestinal manifestations [OR: 2.23 (1.92-2.58, p < 0.001)] and using biologics [OR: 1.13 (1.0-1.26, p = 0.042)] was independently associated with immigrant status in the multivariate analyses. ConclusionsCompared with native-born patients, first-generation-immigrant IBD patients in Spain were younger at disease onset and showed an increased risk of having extraintestinal manifestations and using biologics. Our study suggests a featured phenotype of immigrant IBD patients in Spain, and constitutes a new landmark in the epidemiological characterization of immigrant IBD populations in Southern Europe. |
Note: | Reproducció del document publicat a: https://doi.org/10.3389/fmed.2022.823900 |
It is part of: | Frontiers in Medicine, 2022, vol. 9 |
URI: | http://hdl.handle.net/2445/183759 |
Related resource: | https://doi.org/10.3389/fmed.2022.823900 |
ISSN: | 2813-1169 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
fmed-09-823900.pdf | 1.23 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License